SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.10+0.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (16208)3/17/2003 3:59:05 PM
From: Edscharp  Read Replies (2) of 17367
 
Robert,

"Should xoma/bax post poor crohns results the downside may be minimal"

I believe you may be the ultimate optimist. Seems to me if they post rotten Raptiva data they will be that much closer to their last demise.

Which brings up an interesting question. When a company has established a consistent record of failure how many chances do they get before investors throw in the towel?

It seems to me that it is anti-business and anti-capitalist to give any company infinite opportunities to squander money. At some point the company begins to resemble Jason of horror movie fame. No matter how many shotgun blasts Jason takes....he doesn't die.

I say two more shotgun blasts (raptiva and bpi) and we bury the poor thing and see 'Lord of the Rings'.

:-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext